New pill aims to protect Diabetics' eyesight
Disease control
Not yet recruiting
This study is testing whether an oral medication called SNP318 can safely reduce fluid buildup in the retina and improve vision for people with diabetic macular edema (DME). About 60 participants will take either the drug or a placebo pill daily for 12 weeks, followed by a 4-week…
Phase: PHASE2 • Sponsor: SciNeuro • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC